EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Extracellular PKM2 modulates cancer immunity by regulating macrophage polarity

Guangda Peng, Bin Li, Hongwei Han, Yi Yuan, Falguni Mishra, Yang Huang, Zhi-Ren Liu

Cancer Immunology, Immunotherapy · 09.05.2025 · 74 (7)

DOI: 10.1007/s00262-025-04050-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 09.05.2025. Verfasst von Guangda Peng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Georgia State University, University Plaza, Atlanta, GA, 30303, USA. Hauptthemen laut MEDLINE: Thyroid Hormones, Membrane Proteins, Carrier Proteins, Macrophages. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor controls its immunity by educating its microenvironment, including regulating polarity of tumor associated macrophages. It is well documented that cancer cells release PKM2 to facilitate tumor progression. We report here that the extracellular PKM2 (EcPKM2) modulates tumor immunity by facilitating M2 macrophage polarization in tumors. EcPKM2 interacts with integrin αvβ3 on macrophage to activate integrin-FAK-PI3K signal axis. Activation of FAK-PI3K by EcPKM2 suppresses PTEN expression, which subsequently upregulates arginase1 (Arg1) expression and activity in macrophage to facilitate M2 polarity. Our studies uncover a novel and important mechanism for modulation of tumor immunity. More importantly, an antibody against PKM2 that disrupts the interaction between EcPKM2 and integrin αvβ3 is effective in converting M2 macrophages to M1 macrophages in tumors, suggesting a new therapeutic strategy and target for cancer therapies. Combination of the anti-PKM2 antibody with checkpoint blockades provides enhanced treatment effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid HormonesMembrane ProteinsCarrier ProteinsMacrophagesCell PolarityNeoplasmsTumor-Associated MacrophagesAnimalsHumansMiceThyroid Hormone-Binding ProteinsTumor MicroenvironmentCell Line, TumorIntegrin alphaVbeta3Signal TransductionMice, Inbred C57BL

Stichwörter der Autor:innen

Arginase1Cancer immunotherapyGlycolysisIntegrin αvβ3MacrophagePyruvate kinase M2

Substanzen

Thyroid HormonesMembrane ProteinsThyroid Hormone-Binding ProteinsCarrier ProteinsIntegrin alphaVbeta3

Autor:innen und Institutionen

  • Department of Biology, Georgia State University, University Plaza, Atlanta, GA, 30303, USA.
  • Department of Biology, Georgia State University, University Plaza, Atlanta, GA, 30303, USA. zliu8@gsu.edu.

Förderung

  • NCI NIH HHS

Zitieren

APA

Peng, G., Li, B., Han, H., Yuan, Y., Mishra, F., Huang, Y., & Liu, Z. R. (2025). Extracellular PKM2 modulates cancer immunity by regulating macrophage polarity. Cancer Immunology, Immunotherapy, 74(7). https://doi.org/10.1007/s00262-025-04050-y

Vancouver

Peng G, Li B, Han H, Yuan Y, Mishra F, Huang Y, et al. Extracellular PKM2 modulates cancer immunity by regulating macrophage polarity. Cancer Immunology, Immunotherapy. 2025;74(7). doi:10.1007/s00262-025-04050-y

BibTeX
@article{Peng2025,
  author = {Peng, Guangda and Li, Bin and Han, Hongwei and Yuan, Yi and Mishra, Falguni and Huang, Yang and Liu, Zhi-Ren},
  title = {Extracellular PKM2 modulates cancer immunity by regulating macrophage polarity},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2025},
  volume = {74},
  number = {7},
  doi = {10.1007/s00262-025-04050-y}
}
Kostenlos starten →